Zhejiang Xianju Pharmaceutical (002332.SZ) has obtained the domestic production drug registration certificate for ethinylestradiol tablets.

Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company recently received the "Drug Registration Certificate" (Certificate Number: 2025S00652) approved and issued by the National Medical Products Administration for the desogestrel ethinylestradiol tablets. The company's desogestrel ethinylestradiol tablets have been approved for registration. The indication for desogestrel ethinylestradiol tablets is contraception. N.V.Organon's desogestrel ethinylestradiol tablets are already on the market in several countries including the Netherlands, the United Kingdom, Belgium, and Denmark. The specifications of the desogestrel ethinylestradiol tablets approved by the company this time are consistent with the specifications of the original product that has already been approved for market.